Key Insights

Highlights

Treatment Research

2 treatments under study, led by Verasonics Vantage 256 Ultrasound

Research Leaders

5 sponsors active, led by Carilion Clinic

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting2
Unknown1
Not Yet Recruiting1

Clinical Trials (4)

Research Network

Common Treatments

  • Verasonics Vantage 256 Ultrasound1
  • Ultrasound1

Active Sponsors

  • Carilion Clinic1
  • Universitaire Ziekenhuizen KU Leuven1
  • Ain Shams Maternity Hospital1
  • Birmingham Women's NHS Foundation Trust1
  • Virginia Polytechnic Institute and State University1

Top Investigators

Related Conditions

  • Twin Twin Transfusion Syndrome1
  • Placenta1
  • Ultrasound1
  • Pregnancy1
  • Ultrasound Doppler1

Activity Timeline